RETRACTED ARTICLE:The prognosis and clinicopathology of CXCR4 in gastric cancer patients: A meta-analysis

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 4589-4597

  Han, Mingzhi ^a   Lv, Shunzeng ^a,b   Zhang, Ya ^c   Yi, Ruiyang ^d   Huang, Bin ^a   Fu, Hanhui ^a   Bian, Ruixiang ^c   Li, Xingang ^a  

^a SHANDONG UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c SHANDONG UNIVERSITY   (China)

^d Department of Obstetrics and Gynecology   (United States)

Author keywords

Clinicopathology; CXCR4; Gastric cancer; Meta analysis; Prognosis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN;

ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; GENE EXPRESSION; GENETIC HETEROGENEITY; HAZARD RATIO; HUMAN; LYMPH NODE METASTASIS; META ANALYSIS; MOLECULAR PATHOLOGY; OVERALL SURVIVAL; PRIORITY JOURNAL; STOMACH CANCER; TUMOR INVASION; CHEMISTRY; FEMALE; MALE; MORTALITY; PATHOLOGY; PROGNOSIS; PUBLISHING; STOMACH TUMOR;

FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROGNOSIS; PUBLICATION BIAS; RECEPTORS, CXCR4; STOMACH NEOPLASMS;

EID: 84902995622     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1603-4     Document Type: TB

References (26)

1. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-90.
2. Yoshie O, ImaiT NH. Novel lymphocyte-specific CC chemokines and their receptors. J Leukoc Biol. 1997;62:634-44. (Pubitemid 27519774)
3. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50-6. (Pubitemid 32225831)
4. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. Use of the stromal cell-derived factor-1alpha/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 2002;62:1832-7. (Pubitemid 34408510)
5. Oonakahara K, Matsuyama W, Higashimoto I, Kawabata M, Arimura K, Osame M. Stromal-derived factor-1alpha/CXCL12-CXCR4 axis is involved in the dissemination of NS CLC cells into pleural space. Am J Respir Cell Mol Biol. 2004;30:671-7. (Pubitemid 38591218)
6. Kim J, Mori T, Chen SL, Amersi FF, Martinez SR, Kuo C, et al. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg. 2006;244:113-20. (Pubitemid 44297455)
7. Zhao BC, Wang ZJ, Mao WZ, Ma HC, Han JG, Zhao B, et al. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World J Gastroenterol. 2011;17:2389-96.
8. Lee HJ, Kim SW, Kim HY, Li S, Yun HJ, Song KS, et al. Chemokine receptor CXCR4 expression, function and clinical implications in gastric cancer. Int J Oncol. 2009;34:473-80.
9. Sun TY, Yan W, Zhao YL, Yu PW. CXCR4 expression in gastric cancer and its clinical significance. Chin J Oper Proc Gen Surg. 2011;5:182-7.
10. Tsuboi K, Kodera Y, Nakanishi H, Ito S, Mochizuki Y, Nakayama G, et al. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis. Oncol Rep. 2008;20:1117-23.
11. Zou P, Zhang ZY, Wu JF. Expressions of chemokine CXCL12 and its receptor CXCR4 in gastric cancer and their significance. J Clin Exp Pathal. 2012;28:265-9.
12. Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, et al. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J. 2001;18:705-19. (Pubitemid 33040631)
13. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into metaanalysis. Trials. 2007;8:16.
14. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815-34. (Pubitemid 28562978)
15. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34. (Pubitemid 27387172)
16. Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Arima H, Hirata M, et al. CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol. 2009;35:19-24.
17. Lee HJ, Huang SM, Kim HY, Oh YS, Hwang JY, Liang ZL, et al. Evaluation of the combined expression of chemokine SDF-1 α and its receptor CXCR4 as a prognostic marker for gastric cancer. Exp Ther Med. 2011;2:499-504.
18. Ying J, Xu Q, Zhang G, Liu B, Zhu L. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis. Med Oncol. 2012;29:1716-22.
19. Zhu ZQ, Ning ZL, Shao F, Hu B. Liang W (2012) Expression of CXCR4 in gastric cancer and its relationship with patient prognosis. Acad J Sec Mil Med Univ. 2012;33:43-7.
20. Kwak MK, Hur K, Park DJ, Lee HJ, Lee HS, Kim WH, et al. Expression of chemokine receptors in human gastric cancer. Tumor Biol. 2005;26:65-70. (Pubitemid 40827606)
21. He H, Wang C, Shen Z, Fang Y, Wang X, Chen W, et al. Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer. Plos ONE. 2013;8:e71864.
22. Ingold B, Simon E, Ungethüm U, Kuban RJ, Müller BM, Lupp A, et al. Vascular CXCR4 expression - a novel antiangiogenic target in gastric cancer? Plos ONE. 2010;5:e10087.
23. Fulton AM. The chemokine receptors CXCR4 and CXCR3 in cancer. Curr Oncol Rep. 2009;11:125-31.
24. Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia. 2006;20:1915-24. (Pubitemid 44614878)
25. Begg CB, Berlin JA. Publication bias: a problem in interpreting medical data. J R Stat Soc A. 1988;81:107-15.
26. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.